Title of article
Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures
Author/Authors
Becker، نويسنده , , Richard C. and Scheiman، نويسنده , , James and Dauerman، نويسنده , , Harold L. and Spencer، نويسنده , , Frederick and Rao، نويسنده , , Sunil and Sabatine، نويسنده , , Marc and Johnson، نويسنده , , David A. and Chan، نويسنده , , Frances and Abraham، نويسنده , , Neena S. and Quigley، نويسنده , , Eamonn M.M. Quigley، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2009
Pages
16
From page
2261
To page
2276
Abstract
The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.
Keywords
Coronary Heart Disease , periprocedural risk assessment , platelet antagonists
Journal title
JACC (Journal of the American College of Cardiology)
Serial Year
2009
Journal title
JACC (Journal of the American College of Cardiology)
Record number
1746258
Link To Document